Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-09

Clinical Trial Update: The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the "Phoenix Sign" Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care [NA]

View source ↗

Summary

A completed trial compared lidocaine and papaverine nerve blocks to improve blood flow and clarify imaging for diagnosing nerve compression in foot drop.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)
  • Papaverine (papaverine)

Snippet

Sponsor: US Neuropathy Centers | Conditions: Drop Foot | NA | Status: COMPLETED